This is relevant to breast cancer in which loss of NUMB expression results in reduction of P53 levels and P53-mediated responses, including sensitivity to genotoxic drugs and maintenance of homeostasis in the stem cell compartment (Pece et al. 2004; Tosoni et al. 2015; Tosoni et al. 2017). Here, TP53 is linked to breast carcinoma.